Your browser doesn't support javascript.
loading
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL.
Graf, Solomon A; Lynch, Ryan C; Ujjani, Chaitra S; Gooley, Ted A; Rasmussen, Heather; Coffey, David G; Cowan, Andrew J; Smith, Stephen D; Shadman, Mazyar; Warren, Edus H; Libby, Edward N; Greninger, Alexander L; Fromm, Jonathan R; Gopal, Ajay K.
Afiliação
  • Graf SA; Division of Medical Oncology, University of Washington Medicine, Seattle, WA.
  • Lynch RC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Ujjani CS; Veterans Affairs Puget Sound Health Care System, Seattle, WA.
  • Gooley TA; Division of Medical Oncology, University of Washington Medicine, Seattle, WA.
  • Rasmussen H; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Coffey DG; Division of Medical Oncology, University of Washington Medicine, Seattle, WA.
  • Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Smith SD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Warren EH; Division of Medical Oncology, University of Washington Medicine, Seattle, WA.
  • Libby EN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Greninger AL; Division of Medical Oncology, University of Washington Medicine, Seattle, WA.
  • Fromm JR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Gopal AK; Division of Medical Oncology, University of Washington Medicine, Seattle, WA.
Blood Adv ; 7(5): 687-696, 2023 03 14.
Article em En | MEDLINE | ID: mdl-36385536

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Zona Marginal Tipo Células B / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma de Zona Marginal Tipo Células B / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article